Region: Netherlands

Key Moderna mRNA patent invalidated by EPO

The revocation has major implications for the covid-19 vaccine patent wars

21 November 2023

UPC case data reveals dominance of German IP professionals and firms

IAM breaks down which firms and lawyers/attorneys have been chosen to represent clients at the Unified Patent Court

21 August 2023

Nokia’s battles with Oppo and Vivo underscore the UPC/UP’s importance for SEP owners

The newly operational Unified Patent Court and unitary patent is a boon for standard essential patent owners, even in disputes with Asia-centric implementers

12 June 2023

Netherlands: SEPs and FRAND – litigation, policy and latest developments

Featured in SEP/FRAND Hub 2022/2023

02 December 2022

Netherlands: patent prosecution

Featured in Global Patent Prosecution 2023

National Dutch and European patents are governed by the Dutch Patent Act 1995. The act and the courts have sought to harmonise Dutch patent practice with the European Patent Convention (EPC). Dutch national patents are automatically granted through a registration system, without undergoing substantive examination.

02 December 2022

KPN scores in US suit against Ericsson but some issues remain

The relatively small Dutch telco has enjoyed significant success in an assertion campaign it began in 2021, but there are still cases to resolve

03 November 2022

German and Dutch IP powerhouses create one-stop UPC practice

Law firms Vossius and Brinkhof join forces to offer clients a pan-EU service for the new court when it gets underway next year

12 September 2022

Nokia wins new patent injunction as Dutch Oppo suit backfires

A Dutch sales ban follows a series of German victories for the Finnish company

09 September 2022

Huawei outspends rival telecoms innovators on R&D

Although the Chinese giant is currently number one, doubts have been raised as to whether its current levels of investment are sustainable

26 August 2022

Novartis cross-border injunction win shows why Dutch litigation is so attractive to patentees

Court in The Hague bans drug sales across EU in decision that raises tough questions which the CJEU may need to answer

26 August 2022

Unlock unlimited access to all IAM content